March 26, 2024
Xybion Digital is excited to announce its Xybion’s Preclinical LIMS Unifies and Enhances Laboratory Efficiency and Data Integrity for EnvolBio’s CRO operations.
Princeton, New Jersey, USA, March 26, 2024
– Xybion Corporation announced today its partnership with EnvolBio to digitize lab operations for end-to-end non-clinical process standardization, streamline data for faster lab operation, manage quality, improve data integrity and compliance. This end-to-end preclinical gold standard solution helps the R&D teams with the ability to seamlessly perform study planning, cost management, protocol creation, study execution, data management, reporting, and regulatory submissions of non-clinical research and development studies.As a world-leading, research-driven CRO, EnvolBio creates value through specialized primate studies and preclinical and clinical pharmacology services for drug discovery, toxicology, and clinical trials. “The nonclinical lab processes and data management are a critical part of EnvolBio’s development, and the enhanced processes will make studies a lot more efficient. EnvolBio is excited to partner with Xybion and its end-to-end, fully unified solution, which will support us to run nearly the entire process from a single system. This improves the business user experience significantly, offers more flexibility, and simplifies the IT ecosystem through a single platform instead of operating multiple systems,” says Jacob McDonald, CEO of EnvolBio, responsible for this program.
The Pristima LIMS SaaS software offers a complete digital lab environment:
- Protocol Management
- Planning, Cost and Resource Management
- Toxicology
- Pathology and Digital Pathology
- Histology
- Veterinary Management, IACUC
- Colony Management
- Pharmacy
- Master Schedule, audits, non-conformance, CAPA
- CDSIC SEND
- Historical Controls Database (HCDB), Reporting and Analytics.
- Lab Datalake and Artificial Intelligence
Mr. Kamal Biswas, President and COO of Xybion, says, “We are super excited to start this partnership. Xybion’s LIMS creates an end-to-end digital laboratory execution environment not only for internal EnvolBio existing labs, but it also creates a future expansion path to streamline workflows, automation, data management, and artificial intelligence solutions. I’m very happy to support Jacob and his team to achieve their lab digitization goals.”
“We are exceptionally proud to have been selected by EnvolBio as their partner for the digital acceleration of lab operations. This win bolsters Xybion Digital’s track record as a trusted partner to large multinationals operating in the life sciences industry,” said Dr. Pradip Banerjee, Chairman and CEO of Xybion Digital.
